826
|
Abazov VM, Abbott B, Abolins M, Acharya BS, Adams M, Adams T, Aguilo E, Ahn SH, Ahsan M, Alexeev GD, Alkhazov G, Alton A, Alverson G, Alves GA, Anastasoaie M, Ancu LS, Andeen T, Anderson S, Andrieu B, Anzelc MS, Arnoud Y, Arov M, Arthaud M, Askew A, Asman B, Jesus ACSA, Atramentov O, Autermann C, Avila C, Ay C, Badaud F, Baden A, Bagby L, Baldin B, Bandurin DV, Banerjee P, Banerjee S, Barberis E, Barfuss AF, Bargassa P, Baringer P, Barreto J, Bartlett JF, Bassler U, Bauer D, Beale S, Bean A, Begalli M, Begel M, Belanger-Champagne C, Bellantoni L, Bellavance A, Benitez JA, Beri SB, Bernardi G, Bernhard R, Berntzon L, Bertram I, Besançon M, Beuselinck R, Bezzubov VA, Bhat PC, Bhatnagar V, Biscarat C, Blazey G, Blekman F, Blessing S, Bloch D, Bloom K, Boehnlein A, Boline D, Bolton TA, Borissov G, Bos K, Bose T, Brandt A, Brock R, Brooijmans G, Bross A, Brown D, Buchanan NJ, Buchholz D, Buehler M, Buescher V, Burdin S, Burke S, Burnett TH, Buszello CP, Butler JM, Calfayan P, Calvet S, Cammin J, Caron S, Carvalho W, Casey BCK, Cason NM, Castilla-Valdez H, Chakrabarti S, Chakraborty D, Chan K, Chan KM, Chandra A, Charles F, Cheu E, Chevallier F, Cho DK, Choi S, Choudhary B, Christofek L, Christoudias T, Cihangir S, Claes D, Clément B, Clément C, Coadou Y, Cooke M, Cooper WE, Corcoran M, Couderc F, Cousinou MC, Crépé-Renaudin S, Cutts D, Cwiok M, da Motta H, Das A, Davies G, De K, de Jong P, de Jong SJ, De La Cruz-Burelo E, De Oliveira Martins C, Degenhardt JD, Déliot F, Demarteau M, Demina R, Denisov D, Denisov SP, Desai S, Diehl HT, Diesburg M, Dominguez A, Dong H, Dudko LV, Duflot L, Dugad SR, Duggan D, Duperrin A, Dyer J, Dyshkant A, Eads M, Edmunds D, Ellison J, Elvira VD, Enari Y, Eno S, Ermolov P, Evans H, Evdokimov A, Evdokimov VN, Ferapontov AV, Ferbel T, Fiedler F, Filthaut F, Fisher W, Fisk HE, Ford M, Fortner M, Fox H, Fu S, Fuess S, Gadfort T, Galea CF, Gallas E, Galyaev E, Garcia C, Garcia-Bellido A, Gavrilov V, Gay P, Geist W, Gelé D, Gerber CE, Gershtein Y, Gillberg D, Ginther G, Gollub N, Gómez B, Goussiou A, Grannis PD, Greenlee H, Greenwood ZD, Gregores EM, Grenier G, Gris P, Grivaz JF, Grohsjean A, Grünendahl S, Grünewald MW, Guo F, Guo J, Gutierrez G, Gutierrez P, Haas A, Hadley NJ, Haefner P, Hagopian S, Haley J, Hall I, Hall RE, Han L, Hanagaki K, Hansson P, Harder K, Harel A, Harrington R, Hauptman JM, Hauser R, Hays J, Hebbeker T, Hedin D, Hegeman JG, Heinmiller JM, Heinson AP, Heintz U, Hensel C, Herner K, Hesketh G, Hildreth MD, Hirosky R, Hobbs JD, Hoeneisen B, Hoeth H, Hohlfeld M, Hong SJ, Hooper R, Hossain S, Houben P, Hu Y, Hubacek Z, Hynek V, Iashvili I, Illingworth R, Ito AS, Jabeen S, Jaffré M, Jain S, Jakobs K, Jarvis C, Jesik R, Johns K, Johnson C, Johnson M, Jonckheere A, Jonsson P, Juste A, Käfer D, Kahn S, Kajfasz E, Kalinin AM, Kalk JM, Kalk JR, Kappler S, Karmanov D, Kasper J, Kasper P, Katsanos I, Kau D, Kaur R, Kaushik V, Kehoe R, Kermiche S, Khalatyan N, Khanov A, Kharchilava A, Kharzheev YM, Khatidze D, Kim H, Kim TJ, Kirby MH, Kirsch M, Klima B, Kohli JM, Konrath JP, Kopal M, Korablev VM, Kothari B, Kozelov AV, Krop D, Kryemadhi A, Kuhl T, Kumar A, Kunori S, Kupco A, Kurca T, Kvita J, Lam D, Lammers S, Landsberg G, Lazoflores J, Lebrun P, Lee WM, Leflat A, Lehner F, Lellouch J, Lesne V, Leveque J, Lewis P, Li J, Li L, Li QZ, Lietti SM, Lima JGR, Lincoln D, Linnemann J, Lipaev VV, Lipton R, Liu Y, Liu Z, Lobo L, Lobodenko A, Lokajicek M, Lounis A, Love P, Lubatti HJ, Lyon AL, Maciel AKA, Mackin D, Madaras RJ, Mättig P, Magass C, Magerkurth A, Makovec N, Mal PK, Malbouisson HB, Malik S, Malyshev VL, Mao HS, Maravin Y, Martin B, McCarthy R, Melnitchouk A, Mendes A, Mendoza L, Mercadante PG, Merkin M, Merritt KW, Meyer A, Meyer J, Michaut M, Millet T, Mitrevski J, Molina J, Mommsen RK, Mondal NK, Moore RW, Moulik T, Muanza GS, Mulders M, Mulhearn M, Mundal O, Mundim L, Nagy E, Naimuddin M, Narain M, Naumann NA, Neal HA, Negret JP, Neustroev P, Nilsen H, Noeding C, Nomerotski A, Novaes SF, Nunnemann T, O'dell V, O'neil DC, Obrant G, Ochando C, Onoprienko D, Oshima N, Osta J, Otec R, Y Garzón GJO, Owen M, Padley P, Pangilinan M, Parashar N, Park SJ, Park SK, Parsons J, Partridge R, Parua N, Patwa A, Pawloski G, Perea PM, Peters K, Peters Y, Pétroff P, Petteni M, Piegaia R, Piper J, Pleier MA, Podesta-Lerma PLM, Podstavkov VM, Pogorelov Y, Pol ME, Pompos A, Pope BG, Popov AV, Potter C, da Silva WLP, Prosper HB, Protopopescu S, Qian J, Quadt A, Quinn B, Rakitine A, Rangel MS, Rani KJ, Ranjan K, Ratoff PN, Renkel P, Reucroft S, Rich P, Rijssenbeek M, Ripp-Baudot I, Rizatdinova F, Robinson S, Rodrigues RF, Royon C, Rubinov P, Ruchti R, Safronov G, Sajot G, Sánchez-Hernández A, Sanders MP, Santoro A, Savage G, Sawyer L, Scanlon T, Schaile D, Schamberger RD, Scheglov Y, Schellman H, Schieferdecker P, Schliephake T, Schmitt C, Schwanenberger C, Schwartzman A, Schwienhorst R, Sekaric J, Sengupta S, Severini H, Shabalina E, Shamim M, Shary V, Shchukin AA, Shivpuri RK, Shpakov D, Siccardi V, Simak V, Sirotenko V, Skubic P, Slattery P, Smirnov D, Smith RP, Snow GR, Snow J, Snyder S, Söldner-Rembold S, Sonnenschein L, Sopczak A, Sosebee M, Soustruznik K, Souza M, Spurlock B, Stark J, Steele J, Stolin V, Stone A, Stoyanova DA, Strandberg J, Strandberg S, Strang MA, Strauss M, Ströhmer R, Strom D, Strovink M, Stutte L, Sumowidagdo S, Svoisky P, Sznajder A, Talby M, Tamburello P, Tanasijczuk A, Taylor W, Telford P, Temple J, Tiller B, Tissandier F, Titov M, Tokmenin VV, Tomoto M, Toole T, Torchiani I, Trefzger T, Tsybychev D, Tuchming B, Tully C, Tuts PM, Unalan R, Uvarov L, Uvarov S, Uzunyan S, Vachon B, van den Berg PJ, van Eijk B, Van Kooten R, van Leeuwen WM, Varelas N, Varnes EW, Vartapetian A, Vasilyev IA, Vaupel M, Verdier P, Vertogradov LS, Verzocchi M, Villeneuve-Seguier F, Vint P, Von Toerne E, Voutilainen M, Vreeswijk M, Wagner R, Wahl HD, Wang L, Wang MHLS, Warchol J, Watts G, Wayne M, Weber G, Weber M, Weerts H, Wenger A, Wermes N, Wetstein M, White A, Wicke D, Wilson GW, Wimpenny SJ, Wobisch M, Wood DR, Wyatt TR, Xie Y, Yacoob S, Yamada R, Yan M, Yasuda T, Yatsunenko YA, Yip K, Yoo HD, Youn SW, Yu C, Yu J, Yurkewicz A, Zatserklyaniy A, Zeitnitz C, Zhang D, Zhao T, Zhou B, Zhu J, Zielinski M, Zieminska D, Zieminski A, Zivkovic L, Zutshi V, Zverev EG. Search for stopped gluinos from pp collisions at square root s = 1.96 TeV. PHYSICAL REVIEW LETTERS 2007; 99:131801. [PMID: 17930574 DOI: 10.1103/physrevlett.99.131801] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 05/03/2007] [Indexed: 05/25/2023]
Abstract
Long-lived, heavy particles are predicted in a number of models beyond the standard model of particle physics. We present the first direct search for such particles' decays, occurring up to 100 h after their production and not synchronized with an accelerator bunch crossing. We apply the analysis to the gluino (g), predicted in split supersymmetry, which after hadronization can become charged and lose enough momentum through ionization to come to rest in dense particle detectors. Approximately 410 pb(-1) of pp collisions at square root(s) = 1.96 TeV collected with the D0 detector during Run II of the Fermilab Tevatron collider are analyzed in search of such "stopped gluinos" decaying into a gluon and a neutralino (chi(1)(0)). Limits are placed on the (gluino cross section) x (probability to stop) x [BR(g --> g chi(1)(0))] as a function of the gluino and chi(1)(0) masses, for gluino lifetimes from 30 micros-100 h.
Collapse
|
827
|
Belizon A, Balik E, Kirman I, Remotti H, Ciau N, Jain S, Whelan RL. Insulin-like growth factor binding protein-3 inhibits colitis-induced carcinogenesis. Dis Colon Rectum 2007; 50:1377-83. [PMID: 17668267 DOI: 10.1007/s10350-007-0258-x] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 02/08/2023]
Abstract
PURPOSE Chronic inflammation in the setting of inflammatory bowel disease is thought to result in altered epithelial cell growth regulation and ultimately carcinogenesis. This loss in cell growth regulation may be partially caused by a decrease in circulating intact insulin-like growth factor binding protein-3 (IFGB-3) as a result of chronic inflammation. This study evaluates the effect of IFGB-3 on carcinogenesis in the setting of colitis. METHODS A previously described animal model for colitis-induced carcinogenesis was used. Colitis was induced in both wild-type and IFGB-3 transgenic CD1 mice with a one-week oral exposure to dextran sodium sulfate (2 percent in drinking water). All mice received a single intraperitoneal administration (10 mg/kg body weight) of a genotoxic colonic carcinogen, azoxymethane. At Week 20, the animals were killed and their colons were excised. The colons were examined by a pathologist under blinded conditions. Criteria assessed included the severity of colitis, number of aberrant crypt foci per mouse colon, incidence of colonic adenomas, and mean size of colonic adenomas. RESULTS A total of 20 mice (10 in each group) were included in the study. The severity of colitis was not significantly different between the two groups (mean colitis score wild-type = 13.2; IFGB-3 transgenic = 11; P = not significant). The average number of aberrant crypt foci per colon was significantly lower in the IFGB-3 transgenic mice compared with the wild-type mice (1.5 +/- 1.4 vs. 4.5 +/- 2.7, respectively; P < 0.0001). The number of adenomas per colon was significantly lower in IFGB-3 transgenic group (1.2 +/- 1.8) compared with the wild-type mice (3.7 +/- 2.7; P = 0.005). In addition the average size of adenomas was significantly smaller in IFGB-3 transgenic mice (1.4 +/- 1.3 mm) compared with the wild-type mice (2.6 +/- 2 mm; P = 0.013). CONCLUSIONS IFGB-3 significantly reduces the development of colonic tumors and precursor lesions in the setting of induced murine colitis. It is possible that the loss of IFGB-3 as a result of chronic inflammation may be associated with an increased rate of carcinogenesis in the inflammatory bowel disease setting. Although further studies are necessary, in theory, inhibiting the depletion of IFGB-3 or replacement of IFGB-3 may serve as a novel treatment strategy to prevent the development of colitis-induced carcinogenesis.
Collapse
|
828
|
Mahajan N, Dhawan V, Sharma G, Jain S, Kaul D. ‘Induction of inflammatory gene expression by THP-1 macrophages cultured in normocholesterolaemic hypertensive sera and modulatory effects of green tea polyphenols’. J Hum Hypertens 2007; 22:141-3. [PMID: 17728801 DOI: 10.1038/sj.jhh.1002277] [Citation(s) in RCA: 16] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/09/2022]
Abstract
Hypertension is a disorder controlled by multiple genes and inflammation and vascular remodelling of arteries have been implicated in pathogenesis of this disease. Green tea polyphenols (GrTPs) are rich in antioxidants and are known to inhibit inflammatory responses. A significant time-dependent increase in mRNA expression of both IL-6 and MMP-9 were observed in THP-1 macrophages when cultured in normocholesterolaemic hypertensive sera (P<0.05).
Collapse
|
829
|
Abazov VM, Abbott B, Abolins M, Acharya BS, Adams M, Adams T, Aguilo E, Ahn SH, Ahsan M, Alexeev GD, Alkhazov G, Alton A, Alverson G, Alves GA, Anastasoaie M, Ancu LS, Andeen T, Anderson S, Andrieu B, Anzelc MS, Arnoud Y, Arov M, Arthaud M, Askew A, Asman B, Assis Jesus ACS, Atramentov O, Autermann C, Avila C, Ay C, Badaud F, Baden A, Bagby L, Baldin B, Bandurin DV, Banerjee P, Banerjee S, Barberis E, Barfuss AF, Bargassa P, Baringer P, Barreto J, Bartlett JF, Bassler U, Bauer D, Beale S, Bean A, Begalli M, Begel M, Belanger-Champagne C, Bellantoni L, Bellavance A, Benitez JA, Beri SB, Bernardi G, Bernhard R, Berntzon L, Bertram I, Besançon M, Beuselinck R, Bezzubov VA, Bhat PC, Bhatnagar V, Biscarat C, Blazey G, Blekman F, Blessing S, Bloch D, Bloom K, Boehnlein A, Boline D, Bolton TA, Borissov G, Bos K, Bose T, Brandt A, Brock R, Brooijmans G, Bross A, Brown D, Buchanan NJ, Buchholz D, Buehler M, Buescher V, Burdin S, Burke S, Burnett TH, Buszello CP, Butler JM, Calfayan P, Calvet S, Cammin J, Caron S, Carvalho W, Casey BCK, Cason NM, Castilla-Valdez H, Chakrabarti S, Chakraborty D, Chan K, Chan KM, Chandra A, Charles F, Cheu E, Chevallier F, Cho DK, Choi S, Choudhary B, Christofek L, Christoudias T, Cihangir S, Claes D, Clément B, Clément C, Coadou Y, Cooke M, Cooper WE, Corcoran M, Couderc F, Cousinou MC, Crépé-Renaudin S, Cutts D, Cwiok M, da Motta H, Das A, Davies G, De K, de Jong P, de Jong SJ, De La Cruz-Burelo E, De Oliveira Martins C, Degenhardt JD, Déliot F, Demarteau M, Demina R, Denisov D, Denisov SP, Desai S, Diehl HT, Diesburg M, Dominguez A, Dong H, Dudko LV, Duflot L, Dugad SR, Duggan D, Duperrin A, Dyer J, Dyshkant A, Eads M, Edmunds D, Ellison J, Elvira VD, Enari Y, Eno S, Ermolov P, Evans H, Evdokimov A, Evdokimov VN, Ferapontov AV, Ferbel T, Fiedler F, Filthaut F, Fisher W, Fisk HE, Ford M, Fortner M, Fox H, Fu S, Fuess S, Gadfort T, Galea CF, Gallas E, Galyaev E, Garcia C, Garcia-Bellido A, Gavrilov V, Gay P, Geist W, Gelé D, Gerber CE, Gershtein Y, Gillberg D, Ginther G, Gollub N, Gómez B, Goussiou A, Grannis PD, Greenlee H, Greenwood ZD, Gregores EM, Grenier G, Gris P, Grivaz JF, Grohsjean A, Grünendahl S, Grünewald MW, Guo F, Guo J, Gutierrez G, Gutierrez P, Haas A, Hadley NJ, Haefner P, Hagopian S, Haley J, Hall I, Hall RE, Han L, Hanagaki K, Hansson P, Harder K, Harel A, Harrington R, Hauptman JM, Hauser R, Hays J, Hebbeker T, Hedin D, Hegeman JG, Heinmiller JM, Heinson AP, Heintz U, Hensel C, Herner K, Hesketh G, Hildreth MD, Hirosky R, Hobbs JD, Hoeneisen B, Hoeth H, Hohlfeld M, Hong SJ, Hooper R, Hossain S, Houben P, Hu Y, Hubacek Z, Hynek V, Iashvili I, Illingworth R, Ito AS, Jabeen S, Jaffré M, Jain S, Jakobs K, Jarvis C, Jesik R, Johns K, Johnson C, Johnson M, Jonckheere A, Jonsson P, Juste A, Käfer D, Kahn S, Kajfasz E, Kalinin AM, Kalk JM, Kalk JR, Kappler S, Karmanov D, Kasper J, Kasper P, Katsanos I, Kau D, Kaur R, Kaushik V, Kehoe R, Kermiche S, Khalatyan N, Khanov A, Kharchilava A, Kharzheev YM, Khatidze D, Kim H, Kim TJ, Kirby MH, Kirsch M, Klima B, Kohli JM, Konrath JP, Kopal M, Korablev VM, Kothari B, Kozelov AV, Krop D, Kryemadhi A, Kuhl T, Kumar A, Kunori S, Kupco A, Kurca T, Kvita J, Lam D, Lammers S, Landsberg G, Lazoflores J, Lebrun P, Lee WM, Leflat A, Lehner F, Lellouch J, Lesne V, Leveque J, Lewis P, Li J, Li L, Li QZ, Lietti SM, Lima JGR, Lincoln D, Linnemann J, Lipaev VV, Lipton R, Liu Y, Liu Z, Lobo L, Lobodenko A, Lokajicek M, Lounis A, Love P, Lubatti HJ, Lyon AL, Maciel AKA, Mackin D, Madaras RJ, Mättig P, Magass C, Magerkurth A, Makovec N, Mal PK, Malbouisson HB, Malik S, Malyshev VL, Mao HS, Maravin Y, Martin B, McCarthy R, Melnitchouk A, Mendes A, Mendoza L, Mercadante PG, Merkin M, Merritt KW, Meyer A, Meyer J, Michaut M, Millet T, Mitrevski J, Molina J, Mommsen RK, Mondal NK, Moore RW, Moulik T, Muanza GS, Mulders M, Mulhearn M, Mundal O, Mundim L, Nagy E, Naimuddin M, Narain M, Naumann NA, Neal HA, Negret JP, Neustroev P, Nilsen H, Noeding C, Nomerotski A, Novaes SF, Nunnemann T, O'Dell V, O'Neil DC, Obrant G, Ochando C, Onoprienko D, Oshima N, Osta J, Otec R, Otero Y Garzón GJ, Owen M, Padley P, Pangilinan M, Parashar N, Park SJ, Park SK, Parsons J, Partridge R, Parua N, Patwa A, Pawloski G, Perea PM, Peters K, Peters Y, Pétroff P, Petteni M, Piegaia R, Piper J, Pleier MA, Podesta-Lerma PLM, Podstavkov VM, Pogorelov Y, Pol ME, Pompos A, Pope BG, Popov AV, Potter C, Prado da Silva WL, Prosper HB, Protopopescu S, Qian J, Quadt A, Quinn B, Rakitine A, Rangel MS, Rani KJ, Ranjan K, Ratoff PN, Renkel P, Reucroft S, Rich P, Rijssenbeek M, Ripp-Baudot I, Rizatdinova F, Robinson S, Rodrigues RF, Royon C, Rubinov P, Ruchti R, Safonov G, Sajot G, Sánchez-Hernández A, Sanders MP, Santoro A, Savage G, Sawyer L, Scanlon T, Schaile D, Schamberger RD, Scheglov Y, Schellman H, Schieferdecker P, Schleiphake T, Schmitt C, Schwanenberger C, Schwartzman A, Schwienhorst R, Sekaric J, Sengupta S, Severini H, Shabalina E, Shamim M, Shary V, Shchukin AA, Shivpuri RK, Shpakov D, Siccardi V, Simak V, Sirotenko V, Skubic P, Slattery P, Smirnov D, Smith RP, Snow GR, Snow J, Snyder S, Söldner-Rembold S, Sonnenschein L, Sopczak A, Sosebee M, Soustruznik K, Souza M, Spurlock B, Stark J, Steele J, Stolin V, Stone A, Stoyanova DA, Strandberg J, Strandberg S, Strang MA, Strauss M, Ströhmer R, Strom D, Strovink M, Stutte L, Sumowidagdo S, Svoisky P, Sznajder A, Talby M, Tamburello P, Tanasijczuk A, Taylor W, Telford P, Temple J, Tiller B, Tissandier F, Titov M, Tokmenin VV, Tomoto M, Toole T, Torchiani I, Trefzger T, Tsybychev D, Tuchming B, Tully C, Tuts PM, Unalan R, Uvarov L, Uvarov S, Uzunyan S, Vachon B, van den Berg PJ, van Eijk B, Van Kooten R, van Leeuwen WM, Varelas N, Varnes EW, Vartapetian A, Vasilyev IA, Vaupel M, Verdier P, Vertogradov LS, Verzocchi M, Villeneuve-Seguier F, Vint P, Von Toerne E, Voutilainen M, Vreeswijk M, Wagner R, Wahl HD, Wang L, Wang MHLS, Warchol J, Watts G, Wayne M, Weber G, Weber M, Weerts H, Wenger A, Wermes N, Wetstein M, White A, Wicke D, Wilson GW, Wimpenny SJ, Wobisch M, Wood DR, Wyatt TR, Xie Y, Yacoob S, Yamada R, Yan M, Yasuda T, Yatsunenko YA, Yip K, Yoo HD, Youn SW, Yu C, Yu J, Yurkewicz A, Zatserklyaniy A, Zeitnitz C, Zhang D, Zhao T, Zhou B, Zhu J, Zielinski M, Zieminska D, Zieminski A, Zivkovic L, Zutshi V, Zverev EG. Search for third-generation scalar leptoquarks in pp at square root s=1.96 TeV. PHYSICAL REVIEW LETTERS 2007; 99:061801. [PMID: 17930814 DOI: 10.1103/physrevlett.99.061801] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 05/08/2007] [Indexed: 05/25/2023]
Abstract
We report on a search for charge-1/3 third-generation leptoquarks (LQ) produced in pp collisions at square root s =1.96 TeV using the D0 detector at Fermilab. Third-generation leptoquarks are assumed to be produced in pairs and to decay to a tau neutrino and a b quark with branching fraction B. We place upper limits on sigma(pp --> LQLQ)B2 as a function of the leptoquark mass M(LQ). Assuming B=1, we exclude at the 95% confidence level third-generation scalar leptoquarks with M(LQ)<229 GeV.
Collapse
|
830
|
Abazov VM, Abbott B, Abolins M, Acharya BS, Adams M, Adams T, Aguilo E, Ahn SH, Ahsan M, Alexeev GD, Alkhazov G, Alton A, Alverson G, Alves GA, Anastasoaie M, Ancu LS, Andeen T, Anderson S, Andrieu B, Anzelc MS, Arnoud Y, Arov M, Arthaud M, Askew A, Asman B, Assis Jesus ACS, Atramentov O, Autermann C, Avila C, Ay C, Badaud F, Baden A, Bagby L, Baldin B, Bandurin DV, Banerjee S, Banerjee P, Barberis E, Barfuss AF, Bargassa P, Baringer P, Barreto J, Bartlett JF, Bassler U, Bauer D, Beale S, Bean A, Begalli M, Begel M, Belanger-Champagne C, Bellantoni L, Bellavance A, Benitez JA, Beri SB, Bernardi G, Bernhard R, Berntzon L, Bertram I, Besançon M, Beuselinck R, Bezzubov VA, Bhat PC, Bhatnagar V, Biscarat C, Blazey G, Blekman F, Blessing S, Bloch D, Bloom K, Boehnlein A, Boline D, Bolton TA, Borissov G, Bos K, Bose T, Brandt A, Brock R, Brooijmans G, Bross A, Brown D, Buchanan NJ, Buchholz D, Buehler M, Buescher V, Burdin S, Burke S, Burnett TH, Buszello CP, Butler JM, Calfayan P, Calvet S, Cammin J, Caron S, Carvalho W, Casey BCK, Cason NM, Castilla-Valdez H, Chakrabarti S, Chakraborty D, Chan KM, Chan K, Chandra A, Charles F, Cheu E, Chevallier F, Cho DK, Choi S, Choudhary B, Christofek L, Christoudias T, Cihangir S, Claes D, Clément C, Clément B, Coadou Y, Cooke M, Cooper WE, Corcoran M, Couderc F, Cousinou MC, Crépé-Renaudin S, Cutts D, Cwiok M, da Motta H, Das A, Davies G, De K, de Jong SJ, de Jong P, De La Cruz-Burelo E, De Oliveira Martins C, Degenhardt JD, Déliot F, Demarteau M, Demina R, Denisov D, Denisov SP, Desai S, Diehl HT, Diesburg M, Dominguez A, Dong H, Dudko LV, Duflot L, Dugad SR, Duggan D, Duperrin A, Dyer J, Dyshkant A, Eads M, Edmunds D, Ellison J, Elvira VD, Enari Y, Eno S, Ermolov P, Evans H, Evdokimov A, Evdokimov VN, Ferapontov AV, Ferbel T, Fiedler F, Filthaut F, Fisher W, Fisk HE, Ford M, Fortner M, Fox H, Fu S, Fuess S, Gadfort T, Galea CF, Gallas E, Galyaev E, Garcia C, Garcia-Bellido A, Gavrilov V, Gay P, Geist W, Gelé D, Gerber CE, Gershtein Y, Gillberg D, Ginther G, Gollub N, Gómez B, Goussiou A, Grannis PD, Greenlee H, Greenwood ZD, Gregores EM, Grenier G, Gris P, Grivaz JF, Grohsjean A, Grünendahl S, Grünewald MW, Guo J, Guo F, Gutierrez P, Gutierrez G, Haas A, Hadley NJ, Haefner P, Hagopian S, Haley J, Hall I, Hall RE, Han L, Hanagaki K, Hansson P, Harder K, Harel A, Harrington R, Hauptman JM, Hauser R, Hays J, Hebbeker T, Hedin D, Hegeman JG, Heinmiller JM, Heinson AP, Heintz U, Hensel C, Herner K, Hesketh G, Hildreth MD, Hirosky R, Hobbs JD, Hoeneisen B, Hoeth H, Hohlfeld M, Hong SJ, Hooper R, Hossain S, Houben P, Hu Y, Hubacek Z, Hynek V, Iashvili I, Illingworth R, Ito AS, Jabeen S, Jaffré M, Jain S, Jakobs K, Jarvis C, Jesik R, Johns K, Johnson C, Johnson M, Jonckheere A, Jonsson P, Juste A, Käfer D, Kahn S, Kajfasz E, Kalinin AM, Kalk JR, Kalk JM, Kappler S, Karmanov D, Kasper J, Kasper P, Katsanos I, Kau D, Kaur R, Kaushik V, Kehoe R, Kermiche S, Khalatyan N, Khanov A, Kharchilava A, Kharzheev YM, Khatidze D, Kim H, Kim TJ, Kirby MH, Kirsch M, Klima B, Kohli JM, Konrath JP, Kopal M, Korablev VM, Kothari B, Kozelov AV, Krop D, Kryemadhi A, Kuhl T, Kumar A, Kunori S, Kupco A, Kurca T, Kvita J, Lacroix F, Lam D, Lammers S, Landsberg G, Lazoflores J, Lebrun P, Lee WM, Leflat A, Lehner F, Lellouch J, Lesne V, Leveque J, Lewis P, Li J, Li QZ, Li L, Lietti SM, Lima JGR, Lincoln D, Linnemann J, Lipaev VV, Lipton R, Liu Y, Liu Z, Lobo L, Lobodenko A, Lokajicek M, Lounis A, Love P, Lubatti HJ, Lyon AL, Maciel AKA, Mackin D, Madaras RJ, Mättig P, Magass C, Magerkurth A, Makovec N, Mal PK, Malbouisson HB, Malik S, Malyshev VL, Mao HS, Maravin Y, Martin B, McCarthy R, Melnitchouk A, Mendes A, Mendoza L, Mercadante PG, Merekov YP, Merkin M, Merritt KW, Meyer J, Meyer A, Michaut M, Millet T, Mitrevski J, Molina J, Mommsen RK, Mondal NK, Moore RW, Moulik T, Muanza GS, Mulders M, Mulhearn M, Mundal O, Mundim L, Nagy E, Naimuddin M, Narain M, Naumann NA, Neal HA, Negret JP, Neustroev P, Nilsen H, Nomerotski A, Novaes SF, Nunnemann T, O'Dell V, O'Neil DC, Obrant G, Ochando C, Onoprienko D, Oshima N, Osta J, Otec R, Otero y Garzón GJ, Owen M, Padley P, Pangilinan M, Panov G, Parashar N, Park SJ, Park SK, Parsons J, Partridge R, Parua N, Patwa A, Pawloski G, Penning B, Perea PM, Peters K, Peters Y, Pétroff P, Petteni M, Piegaia R, Piper J, Pleier MA, Podesta-Lerma PLM, Podstavkov VM, Pogorelov Y, Pol ME, Polozov P, Pompos A, Pope BG, Popov AV, Potter C, Prado da Silva WL, Prosper HB, Protopopescu S, Qian J, Quadt A, Quinn B, Rakitine A, Rangel MS, Rani KJ, Ranjan K, Ratoff PN, Renkel P, Reucroft S, Rich P, Rijssenbeek M, Ripp-Baudot I, Rizatdinova F, Robinson S, Rodrigues RF, Royon C, Rozhdestvenski A, Rubinov P, Ruchti R, Safronov G, Sajot G, Sánchez-Hernández A, Sanders MP, Santoro A, Savage G, Sawyer L, Scanlon T, Schaile D, Schamberger RD, Scheglov Y, Schellman H, Schieferdecker P, Schliephake T, Schmitt C, Schwanenberger C, Schwartzman A, Schwienhorst R, Sekaric J, Sengupta S, Severini H, Shabalina E, Shamim M, Shary V, Shchukin AA, Shivpuri RK, Shpakov D, Siccardi V, Simak V, Sirotenko V, Skubic P, Slattery P, Smirnov D, Smith RP, Snow J, Snow GR, Snyder S, Söldner-Rembold S, Sonnenschein L, Sopczak A, Sosebee M, Soustruznik K, Souza M, Spurlock B, Stark J, Steele J, Stolin V, Stone A, Stoyanova DA, Strandberg J, Strandberg S, Strang MA, Strauss M, Strauss E, Ströhmer R, Strom D, Strovink M, Stutte L, Sumowidagdo S, Svoisky P, Sznajder A, Talby M, Tamburello P, Tanasijczuk A, Taylor W, Telford P, Temple J, Tiller B, Tissandier F, Titov M, Tokmenin VV, Tomoto M, Toole T, Torchiani I, Trefzger T, Tsybychev D, Tuchming B, Tully C, Tuts PM, Unalan R, Uvarov S, Uvarov L, Uzunyan S, Vachon B, van den Berg PJ, van Eijk B, Van Kooten R, van Leeuwen WM, Varelas N, Varnes EW, Vartapetian A, Vasilyev IA, Vaupel M, Verdier P, Vertogradov LS, Vertogradova Y, Verzocchi M, Villeneuve-Seguier F, Vint P, Vokac P, Von Toerne E, Voutilainen M, Vreeswijk M, Wagner R, Wahl HD, Wang L, Wang MHLS, Warchol J, Watts G, Wayne M, Weber M, Weber G, Weerts H, Wenger A, Wermes N, Wetstein M, White A, Wicke D, Wilson GW, Wimpenny SJ, Wobisch M, Wood DR, Wyatt TR, Xie Y, Yacoob S, Yamada R, Yan M, Yasuda T, Yatsunenko YA, Yip K, Yoo HD, Youn SW, Yu J, Yu C, Yurkewicz A, Zatserklyaniy A, Zeitnitz C, Zhang D, Zhao T, Zhou B, Zhu J, Zielinski M, Zieminska D, Zieminski A, Zivkovic L, Zutshi V, Zverev EG. Direct observation of the strange b baryon Xib-. PHYSICAL REVIEW LETTERS 2007; 99:052001. [PMID: 17930744 DOI: 10.1103/physrevlett.99.052001] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 06/12/2007] [Indexed: 05/25/2023]
Abstract
We report the first direct observation of the strange b baryon Xi(b)- (Xi(b)+). We reconstruct the decay Xi(b)- -->J/psiXi-, with J/psi-->mu+mu-, and Xi--->Lambdapi--->ppi-pi- in pp collisions at square root of s =1.96 TeV. Using 1.3 fb(-1) of data collected by the D0 detector, we observe 15.2 +/- 4.4(stat)(-0.4)(+1.9)(syst) Xi(b)- candidates at a mass of 5.774 +/- 0.011(stat) +/- 0.015(syst) GeV. The significance of the observed signal is 5.5 sigma, equivalent to a probability of 3.3 x 10(-8) of it arising from a background fluctuation. Normalizing to the decay Lambda(b)-->J/psiLambda, we measure the relative rate sigma(Xi(b-) x B(Xi)b})- -->J/psiXi-)/sigma(Lambda(b)) x B(Lambda(b)-->J/psiLambda) = 0.28+/-0.09(stat)(-0.08)(+0.09)(syst).
Collapse
|
831
|
|
832
|
Iqbal J, Greiner TC, Patel K, Dave BJ, Smith L, Ji J, Wright G, Sanger WG, Pickering DL, Jain S, Horsman DE, Shen Y, Fu K, Weisenburger DD, Hans CP, Campo E, Gascoyne RD, Rosenwald A, Jaffe ES, Delabie J, Rimsza L, Ott G, Müller-Hermelink HK, Connors JM, Vose JM, McKeithan T, Staudt LM, Chan WC. Distinctive patterns of BCL6 molecular alterations and their functional consequences in different subgroups of diffuse large B-cell lymphoma. Leukemia 2007; 21:2332-43. [PMID: 17625604 PMCID: PMC2366166 DOI: 10.1038/sj.leu.2404856] [Citation(s) in RCA: 141] [Impact Index Per Article: 8.3] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/08/2022]
Abstract
Gene expression profiling of diffuse large B-cell lymphoma (DLBCL) has revealed biologically and prognostically distinct subgroups: germinal center B-cell-like (GCB), activated B-cell-like (ABC) and primary mediastinal (PM) DLBCL. The BCL6 gene is often translocated and/or mutated in DLBCL. Therefore, we examined the BCL6 molecular alterations in these DLBCL subgroups, and their impact on BCL6 expression and BCL6 target gene repression. BCL6 translocations at the major breakpoint region (MBR) were detected in 25 (18.8%) of 133 DLBCL cases, with a higher frequency in the PM (33%) and ABC (24%) subgroups than in the GCB (10%) subgroup. Translocations at the alternative breakpoint region (ABR) were detected in five (6.4%) of 78 DLBCL cases, with three cases in ABC and one case each in the GCB and the unclassifiable subgroups. The translocated cases involved IgH and non-IgH partners in about equal frequency and were not associated with different levels of BCL6 mRNA and protein expression. BCL6 mutations were detected in 61% of DLBCL cases, with a significantly higher frequency in the GCB and PM subgroups (>70%) than in the ABC subgroup (44%). Exon-1 mutations were mostly observed in the GCB subgroup. The repression of known BCL6 target genes correlated with the level of BCL6 mRNA and protein expression in GCB and ABC subgroups but not with BCL6 translocation and intronic mutations. No clear inverse correlation between BCL6 expression and p53 expression was observed. Patients with higher BCL6 mRNA or protein expression had a significantly better overall survival. The biological role of BCL6 in translocated cases where repression of known target genes is not demonstrated is intriguing and warrants further investigation.
Collapse
|
833
|
Taneja S, Das K, Saigal S, Ranjan P, Jain S, Garg N, Malik VK, Arora A. Oesophageal leiomyoma: case report and review of literature. TROPICAL GASTROENTEROLOGY : OFFICIAL JOURNAL OF THE DIGESTIVE DISEASES FOUNDATION 2007; 28:131-132. [PMID: 18384005] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 05/26/2023]
|
834
|
Wang J, Jain S, Heller W, Mackie D, Watson V, Dweck M, Coombes RC, Palmieri C. Fulvestrant in advanced breast cancer following following failure of tamoxifen and a third generation aromatase inhibitor. J Clin Oncol 2007. [DOI: 10.1200/jco.2007.25.18_suppl.1073] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
Abstract
1073 Background: Endocrine therapy is a key modality in the management of estrogen receptor positive metastatic breast cancer. Fulvestrant (ICI 182,780) is an estrogen receptor downregulator. It has previously been shown to be as effective as anastrozole in patients who had previously progressed on tamoxifen. Methods: A retrospective study was carried out of metastatic breast cancer patients treated at Charing Cross Hospital between 2002–2005 who had received fulvestrant following treatment failure with tamoxifen and a third generation aromatase inhibitor. All patients were postmenopausal and received fulvestrant 250mg IM every 28 days. Measurable disease was assessed by response evaluation criteria in solid tumors (RECIST). Results: A total of 45 patients were identified with a median age of 60 (range 36 to 90). The ER status was known in 95% (n=43) of patients and was positive in all cases, it was unknown in 2% (n=2). At the time of commencing fulvestrant, 96% (n=43) had metastatic disease and 4% (n=2) locally advanced disease. All patients had received at least 2 lines of prior endocrine therapy (including adjuvant therapy), at time of starting fulvestrant the median number of prior regimens was 3 (range 3–5). Fulvestrant was administered for a median of 4 months (range 1 to 20 months), with 4 patients currently still receiving therapy as of 1 November 2006. Of the 45 patients, 2.2% (n=1) achieved a partial response, while 31% (n=14) achieved stable disease for at least 6 months. Thus, 33.3% (n=15) obtained clinical benefit (defined as PR or SD for at least 6 months). The response rates based on line of therapy will be presented. Of the 45 patients, 41 were evaluable for survival data. The median survival of the remaining patients from the start of fulvestrant therapy was 9 months (range 1 to 48 months). Of the 44 patients, 14% (n=6) remain alive. The treatment was well tolerated and toxicity data will be presented. Conclusions: Fulvestrant is well tolerated and is efficacious as treatment for advanced breast cancer that has failed tamoxifen and a third generation aromatase inhibitors. No significant financial relationships to disclose.
Collapse
|
835
|
Abazov VM, Abbott B, Abolins M, Acharya BS, Adams M, Adams T, Aguilo E, Ahn SH, Ahsan M, Alexeev GD, Alkhazov G, Alton A, Alverson G, Alves GA, Anastasoaie M, Ancu LS, Andeen T, Anderson S, Andrieu B, Anzelc MS, Arnoud Y, Arov M, Askew A, Asman B, Assis Jesus ACS, Atramentov O, Autermann C, Avila C, Ay C, Badaud F, Baden A, Bagby L, Baldin B, Bandurin DV, Banerjee P, Banerjee S, Barberis E, Bargassa P, Baringer P, Barnes C, Barreto J, Bartlett JF, Bassler U, Bauer D, Beale S, Bean A, Begalli M, Begel M, Belanger-Champagne C, Bellantoni L, Bellavance A, Benitez JA, Beri SB, Bernardi G, Bernhard R, Berntzon L, Bertram I, Besançon M, Beuselinck R, Bezzubov VA, Bhat PC, Bhatnagar V, Binder M, Biscarat C, Blackler I, Blazey G, Blekman F, Blessing S, Bloch D, Bloom K, Boehnlein A, Boline D, Bolton TA, Borissov G, Bos K, Bose T, Brandt A, Brock R, Brooijmans G, Bross A, Brown D, Buchanan NJ, Buchholz D, Buehler M, Buescher V, Burdin S, Burke S, Burnett TH, Busato E, Buszello CP, Butler JM, Calfayan P, Calvet S, Cammin J, Caron S, Carvalho W, Casey BCK, Cason NM, Castilla-Valdez H, Chakrabarti S, Chakraborty D, Chan KM, Chandra A, Charles F, Cheu E, Chevallier F, Cho DK, Choi S, Choudhary B, Christofek L, Claes D, Clément B, Clément C, Coadou Y, Cooke M, Cooper WE, Corcoran M, Couderc F, Cousinou MC, Cox B, Crépé-Renaudin S, Cutts D, Cwiok M, da Motta H, Das A, Das M, Davies B, Davies G, De K, de Jong P, de Jong SJ, De La Cruz-Burelo E, De Oliveira Martins C, Degenhardt JD, Déliot F, Demarteau M, Demina R, Denisov D, Denisov SP, Desai S, Diehl HT, Diesburg M, Doidge M, Dominguez A, Dong H, Dudko LV, Duflot L, Dugad SR, Duggan D, Duperrin A, Dyer J, Dyshkant A, Eads M, Edmunds D, Ellison J, Elvira VD, Enari Y, Eno S, Ermolov P, Evans H, Evdokimov A, Evdokimov VN, Feligioni L, Ferapontov AV, Ferbel T, Fiedler F, Filthaut F, Fisher W, Fisk HE, Ford M, Fortner M, Fox H, Fu S, Fuess S, Gadfort T, Galea CF, Gallas E, Galyaev E, Garcia C, Garcia-Bellido A, Gavrilov V, Gay A, Gay P, Geist W, Gelé D, Gelhaus R, Gerber CE, Gershtein Y, Gillberg D, Ginther G, Gollub N, Gómez B, Goussiou A, Grannis PD, Greenlee H, Greenwood ZD, Gregores EM, Grenier G, Gris P, Grivaz JF, Grohsjean A, Grünendahl S, Grünewald MW, Guo F, Guo J, Gutierrez G, Gutierrez P, Haas A, Hadley NJ, Haefner P, Hagopian S, Haley J, Hall I, Hall RE, Han L, Hanagaki K, Hansson P, Harder K, Harel A, Harrington R, Hauptman JM, Hauser R, Hays J, Hebbeker T, Hedin D, Hegeman JG, Heinmiller JM, Heinson AP, Heintz U, Hensel C, Herner K, Hesketh G, Hildreth MD, Hirosky R, Hobbs JD, Hoeneisen B, Hoeth H, Hohlfeld M, Hong SJ, Hooper R, Houben P, Hu Y, Hubacek Z, Hynek V, Iashvili I, Illingworth R, Ito AS, Jabeen S, Jaffré M, Jain S, Jakobs K, Jarvis C, Jenkins A, Jesik R, Johns K, Johnson C, Johnson M, Jonckheere A, Jonsson P, Juste A, Käfer D, Kahn S, Kajfasz E, Kalinin AM, Kalk JM, Kalk JR, Kappler S, Karmanov D, Kasper J, Kasper P, Katsanos I, Kau D, Kaur R, Kehoe R, Kermiche S, Khalatyan N, Khanov A, Kharchilava A, Kharzheev YM, Khatidze D, Kim H, Kim TJ, Kirby MH, Klima B, Kohli JM, Konrath JP, Kopal M, Korablev VM, Kotcher J, Kothari B, Koubarovsky A, Kozelov AV, Krop D, Kryemadhi A, Kuhl T, Kumar A, Kunori S, Kupco A, Kurca T, Kvita J, Lam D, Lammers S, Landsberg G, Lazoflores J, Le Bihan AC, Lebrun P, Lee WM, Leflat A, Lehner F, Lesne V, Leveque J, Lewis P, Li J, Li L, Li QZ, Lietti SM, Lima JGR, Lincoln D, Linnemann J, Lipaev VV, Lipton R, Liu Z, Lobo L, Lobodenko A, Lokajicek M, Lounis A, Love P, Lubatti HJ, Lynker M, Lyon AL, Maciel AKA, Madaras RJ, Mättig P, Magass C, Magerkurth A, Makovec N, Mal PK, Malbouisson HB, Malik S, Malyshev VL, Mao HS, Maravin Y, McCarthy R, Melnitchouk A, Mendes A, Mendoza L, Mercadante PG, Merkin M, Merritt KW, Meyer A, Meyer J, Michaut M, Miettinen H, Millet T, Mitrevski J, Molina J, Mommsen RK, Mondal NK, Monk J, Moore RW, Moulik T, Muanza GS, Mulders M, Mulhearn M, Mundal O, Mundim L, Nagy E, Naimuddin M, Narain M, Naumann NA, Neal HA, Negret JP, Neustroev P, Noeding C, Nomerotski A, Novaes SF, Nunnemann T, O'Dell V, O'Neil DC, Obrant G, Ochando C, Oguri V, Oliveira N, Onoprienko D, Oshima N, Osta J, Otec R, Otero Y Garzón GJ, Owen M, Padley P, Pangilinan M, Parashar N, Park SJ, Park SK, Parsons J, Partridge R, Parua N, Patwa A, Pawloski G, Perea PM, Peters K, Peters Y, Pétroff P, Petteni M, Piegaia R, Piper J, Pleier MA, Podesta-Lerma PLM, Podstavkov VM, Pogorelov Y, Pol ME, Pompos A, Pope BG, Popov AV, Potter C, Prado da Silva WL, Prosper HB, Protopopescu S, Qian J, Quadt A, Quinn B, Rangel MS, Rani KJ, Ranjan K, Ratoff PN, Renkel P, Reucroft S, Rijssenbeek M, Ripp-Baudot I, Rizatdinova F, Robinson S, Rodrigues RF, Royon C, Rubinov P, Ruchti R, Sajot G, Sánchez-Hernández A, Sanders MP, Santoro A, Savage G, Sawyer L, Scanlon T, Schaile D, Schamberger RD, Scheglov Y, Schellman H, Schieferdecker P, Schmitt C, Schwanenberger C, Schwartzman A, Schwienhorst R, Sekaric J, Sengupta S, Severini H, Shabalina E, Shamim M, Shary V, Shchukin AA, Shivpuri RK, Shpakov D, Siccardi V, Sidwell RA, Simak V, Sirotenko V, Skubic P, Slattery P, Smith RP, Snow GR, Snow J, Snyder S, Söldner-Rembold S, Song X, Sonnenschein L, Sopczak A, Sosebee M, Soustruznik K, Souza M, Spurlock B, Stark J, Steele J, Stolin V, Stone A, Stoyanova DA, Strandberg J, Strandberg S, Strang MA, Strauss M, Ströhmer R, Strom D, Strovink M, Stutte L, Sumowidagdo S, Svoisky P, Sznajder A, Talby M, Tamburello P, Taylor W, Telford P, Temple J, Tiller B, Titov M, Tokmenin VV, Tomoto M, Toole T, Torchiani I, Trefzger T, Trincaz-Duvoid S, Tsybychev D, Tuchming B, Tully C, Tuts PM, Unalan R, Uvarov L, Uvarov S, Uzunyan S, Vachon B, van den Berg PJ, van Eijk B, Van Kooten R, van Leeuwen WM, Varelas N, Varnes EW, Vartapetian A, Vasilyev IA, Vaupel M, Verdier P, Vertogradov LS, Verzocchi M, Villeneuve-Seguier F, Vint P, Vlimant JR, Von Toerne E, Voutilainen M, Vreeswijk M, Wahl HD, Wang L, Wang MHLS, Warchol J, Watts G, Wayne M, Weber G, Weber M, Weerts H, Wermes N, Wetstein M, White A, Wicke D, Wilson GW, Wimpenny SJ, Wobisch M, Womersley J, Wood DR, Wyatt TR, Xie Y, Yacoob S, Yamada R, Yan M, Yasuda T, Yatsunenko YA, Yip K, Yoo HD, Youn SW, Yu C, Yu J, Yurkewicz A, Zatserklyaniy A, Zeitnitz C, Zhang D, Zhao T, Zhou B, Zhu J, Zielinski M, Zieminska D, Zieminski A, Zutshi V, Zverev EG. Search for techniparticles in e+jets events at D0. PHYSICAL REVIEW LETTERS 2007; 98:221801. [PMID: 17677833 DOI: 10.1103/physrevlett.98.221801] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 12/08/2006] [Indexed: 05/16/2023]
Abstract
We search for the technicolor process pp-->rhoT/omegaT-->WpiT in events containing one electron and two jets, in data corresponding to an integrated luminosity of 390 pb(-1), recorded by the D0 experiment at the Fermilab Tevatron. Technicolor predicts that technipions pi(T) decay dominantly into bb, bc, or bc, depending on their charge. In these events b and c quarks are identified by their secondary decay vertices within jets. Two analysis methods based on topological variables are presented. Since no excess above the standard model prediction was found, the result is presented as an exclusion in the pi(T) vs rho(T) mass plane for a given set of model parameters.
Collapse
|
836
|
Thorpe JF, Jain S, Marczylo TH, Gescher AJ, Steward WP, Mellon JK. A review of phase III clinical trials of prostate cancer chemoprevention. Ann R Coll Surg Engl 2007; 89:207-11. [PMID: 17394699 PMCID: PMC1964727 DOI: 10.1308/003588407x179125] [Citation(s) in RCA: 19] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/22/2022] Open
Abstract
INTRODUCTION Prostate cancer is an excellent target for chemoprevention strategies; given its late age of onset, any delay in carcinogenesis would lead to a reduction in its incidence. This article reviews all the completed and on-going phase III trials in prostate cancer chemoprevention. PATIENTS AND METHODS All phase III trials of prostate cancer chemoprevention were identified within a Medline search using the keywords 'clinical trial, prostate cancer, chemoprevention'. RESULTS In 2003, the Prostate Cancer Prevention Trial (PCPT) became the first phase III clinical trial of prostate cancer prevention. This landmark study was terminated early due to the 24.8% reduction of prostate cancer prevalence over a 7-year period in those men taking the 5alpha-reductase inhibitor, finasteride. This article reviews the PCPT and the interpretation of the excess high-grade prostate cancer (HGPC) cases in the finasteride group. The lack of relationship between cumulative dose and the HGPC cases, and the possible sampling error of biopsies due to gland volume reduction in the finasteride group refutes the suggestion that this is a genuine increase in HGPC cases. The other on-going phase III clinical trials of prostate cancer chemoprevention - the REDUCE study using dutasteride, and the SELECT study using vitamin E and selenium - are also reviewed. CONCLUSIONS At present, finasteride remains the only intervention shown in long-term prospective phase III clinical trials to reduce the incidence of prostate cancer. Until we have the results of trials using alternative agents including the on-going REDUCE and SELECT trials, the advice given to men interested in prostate cancer prevention must include discussion of the results of the PCPT. The increased rate of HGPC in the finasteride group continues to generate debate; however, finasteride may still be suitable for prostate cancer prevention, particularly in men with lower urinary tract symptoms.
Collapse
|
837
|
Abazov VM, Abbott B, Abolins M, Acharya BS, Adams M, Adams T, Aguilo E, Ahn SH, Ahsan M, Alexeev GD, Alkhazov G, Alton A, Alverson G, Alves GA, Anastasoaie M, Ancu LS, Andeen T, Anderson S, Andrieu B, Anzelc MS, Arnoud Y, Arov M, Askew A, Asman B, Assis Jesus ACS, Atramentov O, Autermann C, Avila C, Ay C, Badaud F, Baden A, Bagby L, Baldin B, Bandurin DV, Banerjee P, Banerjee S, Barberis E, Bargassa P, Baringer P, Barnes C, Barreto J, Bartlett JF, Bassler U, Bauer D, Beale S, Bean A, Begalli M, Begel M, Belanger-Champagne C, Bellantoni L, Bellavance A, Benitez JA, Beri SB, Bernardi G, Bernhard R, Berntzon L, Bertram I, Besançon M, Beuselinck R, Bezzubov VA, Bhat PC, Bhatnagar V, Binder M, Biscarat C, Blackler I, Blazey G, Blekman F, Blessing S, Bloch D, Bloom K, Boehnlein A, Boline D, Bolton TA, Boos EE, Borissov G, Bos K, Bose T, Brandt A, Brock R, Brooijmans G, Bross A, Brown D, Buchanan NJ, Buchholz D, Buehler M, Buescher V, Bunichev V, Burdin S, Burke S, Burnett TH, Busato E, Buszello CP, Butler JM, Calfayan P, Calvet S, Cammin J, Caron S, Carvalho W, Casey BCK, Cason NM, Castilla-Valdez H, Chakrabarti S, Chakraborty D, Chan KM, Chandra A, Charles F, Cheu E, Chevallier F, Cho DK, Choi S, Choudhary B, Christofek L, Claes D, Clément B, Clément C, Coadou Y, Cooke M, Cooper WE, Corcoran M, Couderc F, Cousinou MC, Cox B, Crépé-Renaudin S, Cutts D, Cwiok M, da Motta H, Das A, Das M, Davies B, Davies G, De K, de Jong P, de Jong SJ, De La Cruz-Burelo E, De Oliveira Martins C, Degenhardt JD, Déliot F, Demarteau M, Demina R, Denisov D, Denisov SP, Desai S, Diehl HT, Diesburg M, Doidge M, Dominguez A, Dong H, Dudko LV, Duflot L, Dugad SR, Duggan D, Duperrin A, Dyer J, Dyshkant A, Eads M, Edmunds D, Ellison J, Elvira VD, Enari Y, Eno S, Ermolov P, Evans H, Evdokimov A, Evdokimov VN, Feligioni L, Ferapontov AV, Ferbel T, Fiedler F, Filthaut F, Fisher W, Fisk HE, Ford M, Fortner M, Fox H, Fu S, Fuess S, Gadfort T, Galea CF, Gallas E, Galyaev E, Garcia C, Garcia-Bellido A, Gavrilov V, Gay A, Gay P, Geist W, Gelé D, Gelhaus R, Gerber CE, Gershtein Y, Gillberg D, Ginther G, Gollub N, Gómez B, Goussiou A, Grannis PD, Greenlee H, Greenwood ZD, Gregores EM, Grenier G, Gris P, Grivaz JF, Grohsjean A, Grünendahl S, Grünewald MW, Guo F, Guo J, Gutierrez G, Gutierrez P, Haas A, Hadley NJ, Haefner P, Hagopian S, Haley J, Hall I, Hall RE, Han L, Hanagaki K, Hansson P, Harder K, Harel A, Harrington R, Hauptman JM, Hauser R, Hays J, Hebbeker T, Hedin D, Hegeman JG, Heinmiller JM, Heinson AP, Heintz U, Hensel C, Herner K, Hesketh G, Hildreth MD, Hirosky R, Hobbs JD, Hoeneisen B, Hoeth H, Hohlfeld M, Hong SJ, Hooper R, Houben P, Hu Y, Hubacek Z, Hynek V, Iashvili I, Illingworth R, Ito AS, Jabeen S, Jaffré M, Jain S, Jakobs K, Jarvis C, Jenkins A, Jesik R, Johns K, Johnson C, Johnson M, Jonckheere A, Jonsson P, Juste A, Käfer D, Kahn S, Kajfasz E, Kalinin AM, Kalk JM, Kalk JR, Kappler S, Karmanov D, Kasper J, Kasper P, Katsanos I, Kau D, Kaur R, Kehoe R, Kermiche S, Khalatyan N, Khanov A, Kharchilava A, Kharzheev YM, Khatidze D, Kim H, Kim TJ, Kirby MH, Klima B, Kohli JM, Konrath JP, Kopal M, Korablev VM, Kotcher J, Kothari B, Koubarovsky A, Kozelov AV, Krop D, Kryemadhi A, Kuhl T, Kumar A, Kunori S, Kupco A, Kurca T, Kvita J, Lam D, Lammers S, Landsberg G, Lazoflores J, Le Bihan AC, Lebrun P, Lee WM, Leflat A, Lehner F, Lesne V, Leveque J, Lewis P, Li J, Li L, Li QZ, Lietti SM, Lima JGR, Lincoln D, Linnemann J, Lipaev VV, Lipton R, Liu Z, Lobo L, Lobodenko A, Lokajicek M, Lounis A, Love P, Lubatti HJ, Lynker M, Lyon AL, Maciel AKA, Madaras RJ, Mättig P, Magass C, Magerkurth A, Makovec N, Mal PK, Malbouisson HB, Malik S, Malyshev VL, Mao HS, Maravin Y, McCarthy R, Melnitchouk A, Mendes A, Mendoza L, Mercadante PG, Merkin M, Merritt KW, Meyer A, Meyer J, Michaut M, Miettinen H, Millet T, Mitrevski J, Molina J, Mommsen RK, Mondal NK, Monk J, Moore RW, Moulik T, Muanza GS, Mulders M, Mulhearn M, Mundal O, Mundim L, Nagy E, Naimuddin M, Narain M, Naumann NA, Neal HA, Negret JP, Neustroev P, Noeding C, Nomerotski A, Novaes SF, Nunnemann T, O'Dell V, O'Neil DC, Obrant G, Ochando C, Oguri V, Oliveira N, Onoprienko D, Oshima N, Osta J, Otec R, Otero Y Garzón GJ, Owen M, Padley P, Pangilinan M, Parashar N, Park SJ, Park SK, Parsons J, Partridge R, Parua N, Patwa A, Pawloski G, Perea PM, Perfilov M, Peters K, Peters Y, Pétroff P, Petteni M, Piegaia R, Piper J, Pleier MA, Podesta-Lerma PLM, Podstavkov VM, Pogorelov Y, Pol ME, Pompos A, Pope BG, Popov AV, Potter C, Prado da Silva WL, Prosper HB, Protopopescu S, Qian J, Quadt A, Quinn B, Rangel MS, Rani KJ, Ranjan K, Ratoff PN, Renkel P, Reucroft S, Rijssenbeek M, Ripp-Baudot I, Rizatdinova F, Robinson S, Rodrigues RF, Royon C, Rubinov P, Ruchti R, Sajot G, Sánchez-Hernández A, Sanders MP, Santoro A, Savage G, Sawyer L, Scanlon T, Schaile D, Schamberger RD, Scheglov Y, Schellman H, Schieferdecker P, Schmitt C, Schwanenberger C, Schwartzman A, Schwienhorst R, Sekaric J, Sengupta S, Severini H, Shabalina E, Shamim M, Shary V, Shchukin AA, Shivpuri RK, Shpakov D, Siccardi V, Sidwell RA, Simak V, Sirotenko V, Skubic P, Slattery P, Smith RP, Snow GR, Snow J, Snyder S, Söldner-Rembold S, Song X, Sonnenschein L, Sopczak A, Sosebee M, Soustruznik K, Souza M, Spurlock B, Stark J, Steele J, Stolin V, Stone A, Stoyanova DA, Strandberg J, Strandberg S, Strang MA, Strauss M, Ströhmer R, Strom D, Strovink M, Stutte L, Sumowidagdo S, Svoisky P, Sznajder A, Talby M, Tamburello P, Taylor W, Telford P, Temple J, Tiller B, Titov M, Tokmenin VV, Tomoto M, Toole T, Torchiani I, Trefzger T, Trincaz-Duvoid S, Tsybychev D, Tuchming B, Tully C, Tuts PM, Unalan R, Uvarov L, Uvarov S, Uzunyan S, Vachon B, van den Berg PJ, van Eijk B, Van Kooten R, van Leeuwen WM, Varelas N, Varnes EW, Vartapetian A, Vasilyev IA, Vaupel M, Verdier P, Vertogradov LS, Verzocchi M, Vetterli M, Villeneuve-Seguier F, Vint P, Vlimant JR, Von Toerne E, Voutilainen M, Vreeswijk M, Wahl HD, Wang L, Wang MHLS, Warchol J, Watts G, Wayne M, Weber G, Weber M, Weerts H, Wermes N, Wetstein M, White A, Wicke D, Wilson GW, Wimpenny SJ, Wobisch M, Womersley J, Wood DR, Wyatt TR, Xie Y, Yacoob S, Yamada R, Yan M, Yasuda T, Yatsunenko YA, Yip K, Yoo HD, Youn SW, Yu C, Yu J, Yurkewicz A, Zatserklyaniy A, Zeitnitz C, Zhang D, Zhao T, Zhou B, Zhu J, Zielinski M, Zieminska D, Zieminski A, Zutshi V, Zverev EG. Evidence for production of single top quarks and first direct measurement of |Vtb|. PHYSICAL REVIEW LETTERS 2007; 98:181802. [PMID: 17501561 DOI: 10.1103/physrevlett.98.181802] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 12/22/2006] [Indexed: 05/15/2023]
Abstract
The D0 Collaboration presents first evidence for the production of single top quarks at the Fermilab Tevatron pp[over ] collider. Using a 0.9 fb(-1) dataset, we apply a multivariate analysis to separate signal from background and measure sigma(pp[over ]-->tb+X,tqb+X)=4.9+/-1.4 pb. The probability to measure a cross section at this value or higher in the absence of a signal is 0.035%, corresponding to a 3.4 standard deviation significance. We use the cross section measurement to directly determine the Cabibbo-Kobayashi-Maskawa matrix element that describes the Wtb coupling and find 0.68<|V(tb)|</=1 at 95% C.L. within the standard model.
Collapse
|
838
|
Abazov VM, Abbott B, Abolins M, Acharya BS, Adams M, Adams T, Aguilo E, Ahn SH, Ahsan M, Alexeev GD, Alkhazov G, Alton A, Alverson G, Alves GA, Anastasoaie M, Ancu LS, Andeen T, Anderson S, Andrieu B, Anzelc MS, Arnoud Y, Arov M, Askew A, Asman B, Assis Jesus ACS, Atramentov O, Autermann C, Avila C, Ay C, Badaud F, Baden A, Bagby L, Baldin B, Bandurin DV, Banerjee P, Banerjee S, Barberis E, Bargassa P, Baringer P, Barnes C, Barreto J, Bartlett JF, Bassler U, Bauer D, Beale S, Bean A, Begalli M, Begel M, Belanger-Champagne C, Bellantoni L, Bellavance A, Benitez JA, Beri SB, Bernardi G, Bernhard R, Berntzon L, Bertram I, Besançon M, Beuselinck R, Bezzubov VA, Bhat PC, Bhatnagar V, Binder M, Biscarat C, Blackler I, Blazey G, Blekman F, Blessing S, Bloch D, Bloom K, Boehnlein A, Boline D, Bolton TA, Borissov G, Bos K, Bose T, Brandt A, Brock R, Brooijmans G, Bross A, Brown D, Buchanan NJ, Buchholz D, Buehler M, Buescher V, Burdin S, Burke S, Burnett TH, Busato E, Buszello CP, Butler JM, Calfayan P, Calvet S, Cammin J, Caron S, Carvalho W, Casey BCK, Cason NM, Castilla-Valdez H, Chakrabarti S, Chakraborty D, Chan KM, Chandra A, Charles F, Cheu E, Chevallier F, Cho DK, Choi S, Choudhary B, Christofek L, Claes D, Clément B, Clément C, Coadou Y, Cooke M, Cooper WE, Corcoran M, Couderc F, Cousinou MC, Cox B, Crépé-Renaudin S, Cutts D, Cwiok M, da Motta H, Das A, Das M, Davies B, Davies G, De K, de Jong P, de Jong SJ, De La Cruz-Burelo E, De Oliveira Martins C, Degenhardt JD, Déliot F, Demarteau M, Demina R, Denisov D, Denisov SP, Desai S, Diehl HT, Diesburg M, Doidge M, Dominguez A, Dong H, Dudko LV, Duflot L, Dugad SR, Duggan D, Duperrin A, Dyer J, Dyshkant A, Eads M, Edmunds D, Ellison J, Elvira VD, Enari Y, Eno S, Ermolov P, Evans H, Evdokimov A, Evdokimov VN, Feligioni L, Ferapontov AV, Ferbel T, Fiedler F, Filthaut F, Fisher W, Fisk HE, Ford M, Fortner M, Fox H, Fu S, Fuess S, Gadfort T, Galea CF, Gallas E, Galyaev E, Garcia C, Garcia-Bellido A, Gavrilov V, Gay A, Gay P, Geist W, Gelé D, Gelhaus R, Gerber CE, Gershtein Y, Gillberg D, Ginther G, Gollub N, Gómez B, Goussiou A, Grannis PD, Greenlee H, Greenwood ZD, Gregores EM, Grenier G, Gris P, Grivaz JF, Grohsjean A, Grünendahl S, Grünewald MW, Guo F, Guo J, Gutierrez G, Gutierrez P, Haas A, Hadley NJ, Haefner P, Hagopian S, Haley J, Hall I, Hall RE, Han L, Hanagaki K, Hansson P, Harder K, Harel A, Harrington R, Hauptman JM, Hauser R, Hays J, Hebbeker T, Hedin D, Hegeman JG, Heinmiller JM, Heinson AP, Heintz U, Hensel C, Herner K, Hesketh G, Hildreth MD, Hirosky R, Hobbs JD, Hoeneisen B, Hoeth H, Hohlfeld M, Holubyev K, Hong SJ, Hooper R, Houben P, Hu Y, Hubacek Z, Hynek V, Iashvili I, Illingworth R, Ito AS, Jabeen S, Jaffré M, Jain S, Jakobs K, Jarvis C, Jenkins A, Jesik R, Johns K, Johnson C, Johnson M, Jonckheere A, Jonsson P, Juste A, Käfer D, Kahn S, Kajfasz E, Kalinin AM, Kalk JM, Kalk JR, Kappler S, Karmanov D, Kasper J, Kasper P, Katsanos I, Kau D, Kaur R, Kehoe R, Kermiche S, Khalatyan N, Khanov A, Kharchilava A, Kharzheev YM, Khatidze D, Kim H, Kim TJ, Kirby MH, Klima B, Kohli JM, Konrath JP, Kopal M, Korablev VM, Kotcher J, Kothari B, Koubarovsky A, Kozelov AV, Krop D, Kryemadhi A, Kuhl T, Kumar A, Kunori S, Kupco A, Kurca T, Kvita J, Lam D, Lammers S, Landsberg G, Lazoflores J, Le Bihan AC, Lebrun P, Lee WM, Leflat A, Lehner F, Lesne V, Leveque J, Lewis P, Li J, Li L, Li QZ, Lietti SM, Lima JGR, Lincoln D, Linnemann J, Lipaev VV, Lipton R, Liu Z, Lobo L, Lobodenko A, Lokajicek M, Lounis A, Love P, Lubatti HJ, Lynker M, Lyon AL, Maciel AKA, Madaras RJ, Mättig P, Magass C, Magerkurth A, Makovec N, Mal PK, Malbouisson HB, Malik S, Malyshev VL, Mao HS, Maravin Y, McCarthy R, Melnitchouk A, Mendes A, Mendoza L, Mercadante PG, Merkin M, Merritt KW, Meyer A, Meyer J, Michaut M, Miettinen H, Millet T, Mitrevski J, Molina J, Mommsen RK, Mondal NK, Monk J, Moore RW, Moulik T, Muanza GS, Mulders M, Mulhearn M, Mundal O, Mundim L, Nagy E, Naimuddin M, Narain M, Naumann NA, Neal HA, Negret JP, Neustroev P, Noeding C, Nomerotski A, Novaes SF, Nunnemann T, O'Dell V, O'Neil DC, Obrant G, Ochando C, Oguri V, Oliveira N, Onoprienko D, Oshima N, Osta J, Otec R, Otero Y Garzón GJ, Owen M, Padley P, Pangilinan M, Parashar N, Park SJ, Park SK, Parsons J, Partridge R, Parua N, Patwa A, Pawloski G, Perea PM, Peters K, Peters Y, Pétroff P, Petteni M, Piegaia R, Piper J, Pleier MA, Podesta-Lerma PLM, Podstavkov VM, Pogorelov Y, Pol ME, Pompos A, Pope BG, Popov AV, Potter C, Prado da Silva WL, Prosper HB, Protopopescu S, Qian J, Quadt A, Quinn B, Rangel MS, Rani KJ, Ranjan K, Ratoff PN, Renkel P, Reucroft S, Rijssenbeek M, Ripp-Baudot I, Rizatdinova F, Robinson S, Rodrigues RF, Royon C, Rubinov P, Ruchti R, Sajot G, Sánchez-Hernández A, Sanders MP, Santoro A, Savage G, Sawyer L, Scanlon T, Schaile D, Schamberger RD, Scheglov Y, Schellman H, Schieferdecker P, Schmitt C, Schwanenberger C, Schwartzman A, Schwienhorst R, Sekaric J, Sengupta S, Severini H, Shabalina E, Shamim M, Shary V, Shchukin AA, Shivpuri RK, Shpakov D, Siccardi V, Sidwell RA, Simak V, Sirotenko V, Skubic P, Slattery P, Smith RP, Snow GR, Snow J, Snyder S, Söldner-Rembold S, Song X, Sonnenschein L, Sopczak A, Sosebee M, Soustruznik K, Souza M, Spurlock B, Stark J, Steele J, Stolin V, Stone A, Stoyanova DA, Strandberg J, Strandberg S, Strang MA, Strauss M, Ströhmer R, Strom D, Strovink M, Stutte L, Sumowidagdo S, Svoisky P, Sznajder A, Talby M, Tamburello P, Taylor W, Telford P, Temple J, Tiller B, Titov M, Tokmenin VV, Tomoto M, Toole T, Torchiani I, Trefzger T, Trincaz-Duvoid S, Tsybychev D, Tuchming B, Tully C, Tuts PM, Unalan R, Uvarov L, Uvarov S, Uzunyan S, Vachon B, van den Berg PJ, van Eijk B, Van Kooten R, van Leeuwen WM, Varelas N, Varnes EW, Vartapetian A, Vasilyev IA, Vaupel M, Verdier P, Vertogradov LS, Verzocchi M, Villeneuve-Seguier F, Vint P, Vlimant JR, Von Toerne E, Voutilainen M, Vreeswijk M, Wahl HD, Wang L, Wang MHLS, Warchol J, Watts G, Wayne M, Weber G, Weber M, Weerts H, Wermes N, Wetstein M, White A, Wicke D, Wilson GW, Wimpenny SJ, Wobisch M, Womersley J, Wood DR, Wyatt TR, Xie Y, Yacoob S, Yamada R, Yan M, Yasuda T, Yatsunenko YA, Yip K, Yoo HD, Youn SW, Yu C, Yu J, Yurkewicz A, Zatserklyaniy A, Zeitnitz C, Zhang D, Zhao T, Zhou B, Zhu J, Zielinski M, Zieminska D, Zieminski A, Zutshi V, Zverev EG. Measurement of the charge asymmetry in semileptonic Bs0 decays. PHYSICAL REVIEW LETTERS 2007; 98:151801. [PMID: 17501335 DOI: 10.1103/physrevlett.98.151801] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 01/08/2007] [Indexed: 05/15/2023]
Abstract
We have performed the first direct measurement of the time-integrated flavor untagged charge asymmetry in semileptonic Bs0 decays ASLs,unt by comparing the decay rate of Bs0-->micro+Ds-nuX, where Ds- -->phipi- and phi-->K+K-, with the charge-conjugate Bs0 decay rate. This sample was selected from 1.3 fb-1 of data collected by the D0 experiment in run II of the Fermilab Tevatron collider. We obtain ASLs,unt=[1.23+/-0.97(stat)+/-0.17(syst)]x10(-2). Assuming that Deltam(s)/Gamma(s)>>1, this result can be translated into a measurement of the CP-violating phase in Bs0 mixing: DeltaGamma(s)/Deltam(s)tanphi(s)=[2.45+/-1.93(stat)+/-0.35(syst)]x10(-2).
Collapse
|
839
|
Bishnoi SK, Bardia A, MEENA VYGL, Meena G, Jakhar S, Jain S. Primary Cardiac Sarcoma. Indian J Med Paediatr Oncol 2007. [DOI: 10.1055/s-0041-1733217] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/18/2022] Open
|
840
|
Abazov VM, Abbott B, Abolins M, Acharya BS, Adams M, Adams T, Aguilo E, Ahn SH, Ahsan M, Alexeev GD, Alkhazov G, Alton A, Alverson G, Alves GA, Anastasoaie M, Ancu LS, Andeen T, Anderson S, Andrieu B, Anzelc MS, Arnoud Y, Arov M, Askew A, Asman B, Assis Jesus ACS, Atramentov O, Autermann C, Avila C, Ay C, Badaud F, Baden A, Bagby L, Baldin B, Bandurin DV, Banerjee P, Banerjee S, Barberis E, Barfuss AF, Bargassa P, Baringer P, Barnes C, Barreto J, Bartlett JF, Bassler U, Bauer D, Beale S, Bean A, Begalli M, Begel M, Belanger-Champagne C, Bellantoni L, Bellavance A, Benitez JA, Beri SB, Bernardi G, Bernhard R, Berntzon L, Bertram I, Besançon M, Beuselinck R, Bezzubov VA, Bhat PC, Bhatnagar V, Binder M, Biscarat C, Blackler I, Blazey G, Blekman F, Blessing S, Bloch D, Bloom K, Boehnlein A, Boline D, Bolton TA, Borissov G, Bos K, Bose T, Brandt A, Brock R, Brooijmans G, Bross A, Brown D, Buchanan NJ, Buchholz D, Buehler M, Buescher V, Burdin S, Burke S, Burnett TH, Busato E, Buszello CP, Butler JM, Calfayan P, Calvet S, Cammin J, Caron S, Carvalho W, Casey BCK, Cason NM, Castilla-Valdez H, Chakrabarti S, Chakraborty D, Chan K, Chan KM, Chandra A, Charles F, Cheu E, Chevallier F, Cho DK, Choi S, Choudhary B, Christofek L, Christoudias T, Claes D, Clément B, Clément C, Coadou Y, Cooke M, Cooper WE, Corcoran M, Couderc F, Cousinou MC, Cox B, Crépé-Renaudin S, Cutts D, Cwiok M, da Motta H, Das A, Davies B, Davies G, De K, de Jong P, de Jong SJ, De La Cruz-Burelo E, De Oliveira Martins C, Degenhardt JD, Déliot F, Demarteau M, Demina R, Denisov D, Denisov SP, Desai S, Diehl HT, Diesburg M, Doidge M, Dominguez A, Dong H, Dudko LV, Duflot L, Dugad SR, Duggan D, Duperrin A, Dyer J, Dyshkant A, Eads M, Edmunds D, Ellison J, Elvira VD, Enari Y, Eno S, Ermolov P, Evans H, Evdokimov A, Evdokimov VN, Ferapontov AV, Ferbel T, Fiedler F, Filthaut F, Fisher W, Fisk HE, Ford M, Fortner M, Fox H, Fu S, Fuess S, Gadfort T, Galea CF, Gallas E, Galyaev E, Garcia C, Garcia-Bellido A, Gavrilov V, Gay P, Geist W, Gelé D, Gerber CE, Gershtein Y, Gillberg D, Ginther G, Gollub N, Gómez B, Goussiou A, Grannis PD, Greenlee H, Greenwood ZD, Gregores EM, Grenier G, Gris P, Grivaz JF, Grohsjean A, Grünendahl S, Grünewald MW, Guo F, Guo J, Gutierrez G, Gutierrez P, Haas A, Hadley NJ, Haefner P, Hagopian S, Haley J, Hall I, Hall RE, Han L, Hanagaki K, Hansson P, Harder K, Harel A, Harrington R, Hauptman JM, Hauser R, Hays J, Hebbeker T, Hedin D, Hegeman JG, Heinmiller JM, Heinson AP, Heintz U, Hensel C, Herner K, Hesketh G, Hildreth MD, Hirosky R, Hobbs JD, Hoeneisen B, Hoeth H, Hohlfeld M, Hong SJ, Hooper R, Houben P, Hu Y, Hubacek Z, Hynek V, Iashvili I, Illingworth R, Ito AS, Jabeen S, Jaffré M, Jain S, Jakobs K, Jarvis C, Jenkins A, Jesik R, Johns K, Johnson C, Johnson M, Jonckheere A, Jonsson P, Juste A, Käfer D, Kahn S, Kajfasz E, Kalinin AM, Kalk JM, Kalk JR, Kappler S, Karmanov D, Kasper J, Kasper P, Katsanos I, Kau D, Kaur R, Kehoe R, Kermiche S, Khalatyan N, Khanov A, Kharchilava A, Kharzheev YM, Khatidze D, Kim H, Kim TJ, Kirby MH, Klima B, Kohli JM, Konrath JP, Kopal M, Korablev VM, Kotcher J, Kothari B, Koubarovsky A, Kozelov AV, Krop D, Kryemadhi A, Kuhl T, Kumar A, Kunori S, Kupco A, Kurca T, Kvita J, Lam D, Lammers S, Landsberg G, Lazoflores J, Lebrun P, Lee WM, Leflat A, Lehner F, Lesne V, Leveque J, Lewis P, Li J, Li L, Li QZ, Lietti SM, Lima JGR, Lincoln D, Linnemann J, Lipaev VV, Lipton R, Liu Z, Lobo L, Lobodenko A, Lokajicek M, Lounis A, Love P, Lubatti HJ, Lynker M, Lyon AL, Maciel AKA, Madaras RJ, Mättig P, Magass C, Magerkurth A, Makovec N, Mal PK, Malbouisson HB, Malik S, Malyshev VL, Mao HS, Maravin Y, Martin B, McCarthy R, Melnitchouk A, Mendes A, Mendoza L, Mercadante PG, Merkin M, Merritt KW, Meyer A, Meyer J, Michaut M, Miettinen H, Millet T, Mitrevski J, Molina J, Mommsen RK, Mondal NK, Monk J, Moore RW, Moulik T, Muanza GS, Mulders M, Mulhearn M, Mundal O, Mundim L, Nagy E, Naimuddin M, Narain M, Naumann NA, Neal HA, Negret JP, Neustroev P, Nilsen H, Noeding C, Nomerotski A, Novaes SF, Nunnemann T, O'Dell V, O'Neil DC, Obrant G, Ochando C, Oguri V, Oliveira N, Onoprienko D, Oshima N, Osta J, Otec R, Otero y Garzón GJ, Owen M, Padley P, Pangilinan M, Parashar N, Park SJ, Park SK, Parsons J, Partridge R, Parua N, Patwa A, Pawloski G, Perea PM, Peters K, Peters Y, Pétroff P, Petteni M, Piegaia R, Piper J, Pleier MA, Podesta-Lerma PLM, Podstavkov VM, Pogorelov Y, Pol ME, Pompos A, Pope BG, Popov AV, Potter C, Prado da Silva WL, Prosper HB, Protopopescu S, Qian J, Quadt A, Quinn B, Rangel MS, Rani KJ, Ranjan K, Ratoff PN, Renkel P, Reucroft S, Rijssenbeek M, Ripp-Baudot I, Rizatdinova F, Robinson S, Rodrigues RF, Royon C, Rubinov P, Ruchti R, Sajot G, Sánchez-Hernández A, Sanders MP, Santoro A, Savage G, Sawyer L, Scanlon T, Schaile D, Schamberger RD, Scheglov Y, Schellman H, Schieferdecker P, Schmitt C, Schwanenberger C, Schwartzman A, Schwienhorst R, Sekaric J, Sengupta S, Severini H, Shabalina E, Shamim M, Shary V, Shchukin AA, Shivpuri RK, Shpakov D, Siccardi V, Sidwell RA, Simak V, Sirotenko V, Skubic P, Slattery P, Smirnov D, Smith RP, Snow GR, Snow J, Snyder S, Söldner-Rembold S, Sonnenschein L, Sopczak A, Sosebee M, Soustruznik K, Souza M, Spurlock B, Stark J, Steele J, Stolin V, Stone A, Stoyanova DA, Strandberg J, Strandberg S, Strang MA, Strauss M, Ströhmer R, Strom D, Strovink M, Stutte L, Sumowidagdo S, Svoisky P, Sznajder A, Talby M, Tamburello P, Taylor W, Telford P, Temple J, Tiller B, Tissandier F, Titov M, Tokmenin VV, Tomoto M, Toole T, Torchiani I, Trefzger T, Trincaz-Duvoid S, Tsybychev D, Tuchming B, Tully C, Tuts PM, Unalan R, Uvarov L, Uvarov S, Uzunyan S, Vachon B, van den Berg PJ, van Eijk B, Van Kooten R, van Leeuwen WM, Varelas N, Varnes EW, Vartapetian A, Vasilyev IA, Vaupel M, Verdier P, Vertogradov LS, Verzocchi M, Villeneuve-Seguier F, Vint P, Vlimant JR, Von Toerne E, Voutilainen M, Vreeswijk M, Wahl HD, Wang L, Wang MHLS, Warchol J, Watts G, Wayne M, Weber G, Weber M, Weerts H, Wenger A, Wermes N, Wetstein M, White A, Wicke D, Wilson GW, Wimpenny SJ, Wobisch M, Wood DR, Wyatt TR, Xie Y, Yacoob S, Yamada R, Yan M, Yasuda T, Yatsunenko YA, Yip K, Yoo HD, Youn SW, Yu C, Yu J, Yurkewicz A, Zatserklyaniy A, Zeitnitz C, Zhang D, Zhao T, Zhou B, Zhu J, Zielinski M, Zieminska D, Zieminski A, Zutshi V, Zverev EG. Lifetime difference and CP-violating phase in the Bs0 system. PHYSICAL REVIEW LETTERS 2007; 98:121801. [PMID: 17501111 DOI: 10.1103/physrevlett.98.121801] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 01/10/2007] [Indexed: 05/15/2023]
Abstract
From an analysis of the decay Bs0-->J/psi phi, we obtain the width difference between the light and heavy mass eigenstates DeltaGamma identical with (GammaL-GammaH)=0.17+/-0.09(stat)+/-0.02(syst) ps-1 and the CP-violating phase phis=-0.79+/-0.56(stat)(-0.01)(+0.14)(syst). Under the hypothesis of no CP violation (phis identical with 0), we obtain 1/Gamma=tau(Bs0)=1.52+/-0.08(stat)(-0.03)(+0.01)(syst) ps and DeltaGamma=0.12(-0.10)(+0.08)(stat)+/-0.02(syst) ps-1. The data sample corresponds to an integrated luminosity of about 1.1 fb-1 accumulated with the D0 detector at the Fermilab Tevatron collider. This is the first direct measurement of the CP-violating mixing phase in the Bs0 system.
Collapse
|
841
|
Izadi S, Stewart RMK, Jain S. Bilateral posterior dislocation of the crystalline lens after a head injury sustained during a seizure. Emerg Med J 2007; 24:e6. [PMID: 17183030 PMCID: PMC2658178 DOI: 10.1136/emj.2006.041533] [Citation(s) in RCA: 8] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/03/2022]
Abstract
This article presents a case of bilateral posterior dislocations of the crystalline lens in a patient with epilepsy who presented with reduced vision and anisocoria 2 weeks after having sustained head injuries during a seizure. The possibility of lens dislocation was raised only at this time, and subsequently confirmed on computed tomography. Such patients may require prompt referral to the ophthalmologist to treat complications such as functional aphakia, uveitis and more seriously pupillary block glaucoma. This case highlights the importance of ocular examination of head injuries to rule out possible ophthalmological pathology.
Collapse
|
842
|
Jain S. Screening for suspicious macular lesions using a telemedicine link. Eye (Lond) 2007; 21:302. [PMID: 16980928 DOI: 10.1038/sj.eye.6702566] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/09/2022] Open
|
843
|
McGory M, Zingmond D, Jain S, Foster N, Leonardi M, Maggard M, Ko C. 84. J Surg Res 2007. [DOI: 10.1016/j.jss.2006.12.095] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
|
844
|
Jain S. Reply to Mr Ali. Eye (Lond) 2007. [DOI: 10.1038/sj.eye.6702485] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/09/2022] Open
|
845
|
Abazov VM, Abbott B, Abolins M, Acharya BS, Adams M, Adams T, Agelou M, Ahn SH, Ahsan M, Alexeev GD, Alkhazov G, Alton A, Alverson G, Alves GA, Anastasoaie M, Andeen T, Anderson S, Andrieu B, Anzelc MS, Arnoud Y, Arov M, Askew A, Asman B, Assis Jesus ACS, Atramentov O, Autermann C, Avila C, Ay C, Badaud F, Baden A, Bagby L, Baldin B, Bandurin DV, Banerjee P, Banerjee S, Barberis E, Bargassa P, Baringer P, Barnes C, Barreto J, Bartlett JF, Bassler U, Bauer D, Bean A, Begalli M, Begel M, Belanger-Champagne C, Bellantoni L, Bellavance A, Benitez JA, Beri SB, Bernardi G, Bernhard R, Berntzon L, Bertram I, Besançon M, Beuselinck R, Bezzubov VA, Bhat PC, Bhatnagar V, Binder M, Biscarat C, Black KM, Blackler I, Blazey G, Blekman F, Blessing S, Bloch D, Bloom K, Blumenschein U, Boehnlein A, Boeriu O, Bolton TA, Borissov G, Bos K, Bose T, Brandt A, Brock R, Brooijmans G, Bross A, Brown D, Buchanan NJ, Buchholz D, Buehler M, Buescher V, Burdin S, Burke S, Burnett TH, Busato E, Buszello CP, Butler JM, Calfayan P, Calvet S, Cammin J, Caron S, Carvalho W, Casey BCK, Cason NM, Castilla-Valdez H, Chakraborty D, Chan KM, Chandra A, Charles F, Cheu E, Chevallier F, Cho DK, Choi S, Choudhary B, Christofek L, Claes D, Clément B, Clément C, Coadou Y, Cooke M, Cooper WE, Coppage D, Corcoran M, Cousinou MC, Cox B, Crépé-Renaudin S, Cutts D, Cwiok M, da Motta H, Das A, Das M, Davies B, Davies G, Davis GA, De K, de Jong P, de Jong SJ, De La Cruz-Burelo E, De Oliveira Martins C, Degenhardt JD, Déliot F, Demarteau M, Demina R, Demine P, Denisov D, Denisov SP, Desai S, Diehl HT, Diesburg M, Doidge M, Dominguez A, Dong H, Dudko LV, Duflot L, Dugad SR, Duggan D, Duperrin A, Dyer J, Dyshkant A, Eads M, Edmunds D, Edwards T, Ellison J, Elmsheuser J, Elvira VD, Eno S, Ermolov P, Evans H, Evdokimov A, Evdokimov VN, Fatakia SN, Feligioni L, Ferapontov AV, Ferbel T, Fiedler F, Filthaut F, Fisher W, Fisk HE, Fleck I, Ford M, Fortner M, Fox H, Fu S, Fuess S, Gadfort T, Galea CF, Gallas E, Galyaev E, Garcia C, Garcia-Bellido A, Gardner J, Gavrilov V, Gay A, Gay P, Gelé D, Gelhaus R, Gerber CE, Gershtein Y, Gillberg D, Ginther G, Gollub N, Gómez B, Goussiou A, Grannis PD, Greenlee H, Greenwood ZD, Gregores EM, Grenier G, Gris P, Grivaz JF, Grünendahl S, Grünewald MW, Guo F, Guo J, Gutierrez G, Gutierrez P, Haas A, Hadley NJ, Haefner P, Hagopian S, Haley J, Hall I, Hall RE, Han L, Hanagaki K, Hansson P, Harder K, Harel A, Harrington R, Hauptman JM, Hauser R, Hays J, Hebbeker T, Hedin D, Hegeman JG, Heinmiller JM, Heinson AP, Heintz U, Hensel C, Herner K, Hesketh G, Hildreth MD, Hirosky R, Hobbs JD, Hoeneisen B, Hoeth H, Hohlfeld M, Hong SJ, Hooper R, Houben P, Hu Y, Hubacek Z, Hynek V, Iashvili I, Illingworth R, Ito AS, Jabeen S, Jaffré M, Jain S, Jakobs K, Jarvis C, Jenkins A, Jesik R, Johns K, Johnson C, Johnson M, Jonckheere A, Jonsson P, Juste A, Käfer D, Kahn S, Kajfasz E, Kalinin AM, Kalk JM, Kalk JR, Kappler S, Karmanov D, Kasper J, Kasper P, Katsanos I, Kau D, Kaur R, Kehoe R, Kermiche S, Khalatyan N, Khanov A, Kharchilava A, Kharzheev YM, Khatidze D, Kim H, Kim TJ, Kirby MH, Klima B, Kohli JM, Konrath JP, Kopal M, Korablev VM, Kotcher J, Kothari B, Koubarovsky A, Kozelov AV, Kozminski J, Krop D, Kryemadhi A, Kuhl T, Kumar A, Kunori S, Kupco A, Kurca T, Kvita J, Lammers S, Landsberg G, Lazoflores J, Le Bihan AC, Lebrun P, Lee WM, Leflat A, Lehner F, Lesne V, Leveque J, Lewis P, Li J, Li QZ, Lima JGR, Lincoln D, Linnemann J, Lipaev VV, Lipton R, Liu Z, Lobo L, Lobodenko A, Lokajicek M, Lounis A, Love P, Lubatti HJ, Lynker M, Lyon AL, Maciel AKA, Madaras RJ, Mättig P, Magass C, Magerkurth A, Magnan AM, Makovec N, Mal PK, Malbouisson HB, Malik S, Malyshev VL, Mao HS, Maravin Y, Martens M, McCarthy R, Meder D, Melnitchouk A, Mendes A, Mendoza L, Merkin M, Merritt KW, Meyer A, Meyer J, Michaut M, Miettinen H, Millet T, Mitrevski J, Molina J, Mondal NK, Monk J, Moore RW, Moulik T, Muanza GS, Mulders M, Mulhearn M, Mundim L, Mutaf YD, Nagy E, Naimuddin M, Narain M, Naumann NA, Neal HA, Negret JP, Neustroev P, Noeding C, Nomerotski A, Novaes SF, Nunnemann T, O'dell V, O'neil DC, Obrant G, Oguri V, Oliveira N, Oshima N, Otec R, Otero Y Garzón GJ, Owen M, Padley P, Parashar N, Park SJ, Park SK, Parsons J, Partridge R, Parua N, Patwa A, Pawloski G, Perea PM, Perez E, Peters K, Pétroff P, Petteni M, Piegaia R, Piper J, Pleier MA, Podesta-Lerma PLM, Podstavkov VM, Pogorelov Y, Pol ME, Pompos A, Pope BG, Popov AV, Potter C, Prado da Silva WL, Prosper HB, Protopopescu S, Qian J, Quadt A, Quinn B, Rangel MS, Rani KJ, Ranjan K, Ratoff PN, Renkel P, Reucroft S, Rijssenbeek M, Ripp-Baudot I, Rizatdinova F, Robinson S, Rodrigues RF, Royon C, Rubinov P, Ruchti R, Rud VI, Sajot G, Sánchez-Hernández A, Sanders MP, Santoro A, Savage G, Sawyer L, Scanlon T, Schaile D, Schamberger RD, Scheglov Y, Schellman H, Schieferdecker P, Schmitt C, Schwanenberger C, Schwartzman A, Schwienhorst R, Sekaric J, Sengupta S, Severini H, Shabalina E, Shamim M, Shary V, Shchukin AA, Shephard WD, Shivpuri RK, Shpakov D, Siccardi V, Sidwell RA, Simak V, Sirotenko V, Skubic P, Slattery P, Smith RP, Snow GR, Snow J, Snyder S, Söldner-Rembold S, Song X, Sonnenschein L, Sopczak A, Sosebee M, Soustruznik K, Souza M, Spurlock B, Stark J, Steele J, Stolin V, Stone A, Stoyanova DA, Strandberg J, Strandberg S, Strang MA, Strauss M, Ströhmer R, Strom D, Strovink M, Stutte L, Sumowidagdo S, Sznajder A, Talby M, Tamburello P, Taylor W, Telford P, Temple J, Tiller B, Titov M, Tokmenin VV, Tomoto M, Toole T, Torchiani I, Towers S, Trefzger T, Trincaz-Duvoid S, Tsybychev D, Tuchming B, Tully C, Turcot AS, Tuts PM, Unalan R, Uvarov L, Uvarov S, Uzunyan S, Vachon B, van den Berg PJ, Van Kooten R, van Leeuwen WM, Varelas N, Varnes EW, Vartapetian A, Vasilyev IA, Vaupel M, Verdier P, Vertogradov LS, Verzocchi M, Villeneuve-Seguier F, Vint P, Vlimant JR, Von Toerne E, Voutilainen M, Vreeswijk M, Wahl HD, Wang L, Wang MHLS, Warchol J, Watts G, Wayne M, Weber M, Weerts H, Wermes N, Wetstein M, White A, Wicke D, Wilson GW, Wimpenny SJ, Wobisch M, Womersley J, Wood DR, Wyatt TR, Xie Y, Xuan N, Yacoob S, Yamada R, Yan M, Yasuda T, Yatsunenko YA, Yip K, Yoo HD, Youn SW, Yu C, Yu J, Yurkewicz A, Zatserklyaniy A, Zeitnitz C, Zhang D, Zhao T, Zhou B, Zhu J, Zielinski M, Zieminska D, Zieminski A, Zutshi V, Zverev EG. Experimental discrimination between charge 2e/3 top quark and charge 4e/3 exotic quark production scenarios. PHYSICAL REVIEW LETTERS 2007; 98:041801. [PMID: 17358756 DOI: 10.1103/physrevlett.98.041801] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 08/18/2006] [Indexed: 05/14/2023]
Abstract
We present the first experimental discrimination between the 2e/3 and 4e/3 top quark electric charge scenarios, using top quark pairs (tt) produced in pp collisions at (square root) s = 1.96 TeV by the Fermilab Tevatron Collider. We use 370 pb;{-1} of data collected by the D0 experiment and select events with at least one high transverse momentum electron or muon, high transverse energy imbalance, and four or more jets. We discriminate between b- and b-quark jets by using the charge and momenta of tracks within the jet cones. The data are consistent with the expected electric charge, |q|=2e/3. We exclude, at the 92% C.L., that the sample is solely due to the production of exotic quark pairs QQ with |q|=4e/3. We place an upper limit on the fraction of QQ pairs rho<0.80 at the 90% C.L.
Collapse
|
846
|
Beotra A, Lal R, Khanduja R, Jain S, Kaur T, Reddy M. Analysis of glucocorticosteroids by atmospheric pressure chemical ionization-liquid chromatography mass spectrometry (APCI-C/MS/MS). Indian J Pharmacol 2007. [DOI: 10.4103/0253-7613.33437] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/04/2022] Open
|
847
|
Maheshwari RK, Deswal S, Tiwari D, Ali N, Pothen B, Jain S. Novel spectrophotometric estimation of frusemide using hydrotropic solubilization phenomenon. Indian J Pharm Sci 2007. [DOI: 10.4103/0250-474x.39443] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022] Open
|
848
|
Jain S, Kharpate S, Vadnerkar G, Jain D. Evaluation of hepatoprotective activity of ethanol extract of Ptrospermum acerifolium ster leaves. Indian J Pharm Sci 2007. [DOI: 10.4103/0250-474x.39453] [Citation(s) in RCA: 8] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022] Open
|
849
|
Andrulis M, Chatterjee M, Jain S, Stühmer T, Ungethüm U, Kuban RJ, Lorentz H, Bommert K, Topp M, Kramer D, Müller-Hermelinks HK, Einsele H, Bargou RC, Greiner A. [Heat shock protein 90 alpha und beta are overexpressed in multiple myeloma cells and critically contribute to survival]. VERHANDLUNGEN DER DEUTSCHEN GESELLSCHAFT FUR PATHOLOGIE 2007; 91:330-337. [PMID: 18314631] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Subscribe] [Scholar Register] [Indexed: 05/26/2023]
Abstract
HSP90's are overexpressed in different cancer types and they probably are required to sustain aberrant signalling in malignant cells. Recently, pharmacological inhibition of HSP90 was found to suppress growth of myeloma cell lines and in primary myeloma cells. Therefore, we wanted to investigate the role of HSP90alpha and HSP90beta in the pathogenesis of malignant myeloma (MM) in more detail. Immunohistochemistry was employed to examine the expression of HSP90alpha and HSP90beta in MM. The importance of HSP90 for survival of MM -cells was investigated by SiRNA-mediated knockdown of HSP90 and blockade of the IL-6R/STAT3 and the MAPK signaling pathways in vitro. HSP90alpha and HSP90beta were overexpressed in majority of investigated MM cases, but not in MGUS or in normal plasma cells. SiRNA-mediated knockdown of HSP90 or treatment with the novel HSP90 inhibitor 17-DMAG attenuated the levels of STAT3 and phospho-ERK and decreased the viability of MM cells. The knockdown of HSP90alpha was sufficient to induce apoptosis. This effect was strongly increased when both HSP90s were targeted, indicating a cooperation of both. HSP90 critically contributes to myeloma survival in the context of its microenvironment and therefore strengthen the potential value of HSP90 as a therapeutic target.
Collapse
|
850
|
Beotra A, Jain S, Kaur T, Lal R, Reddy M. Purification of urine samples to improve detection limit of anabolic agents. Indian J Pharmacol 2007. [DOI: 10.4103/0253-7613.30762] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/04/2022] Open
|